- The trend backdrop is active with a 7-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
688710
SHH
Week ended 07 Aug 2026
Weekly Investor Report
Shanghai InnoStar Bio-tech Co., Ltd. · Healthcare · Drug Manufacturers - General
Latest close
90.69 CNY
27.4%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 41.1% above the Trend Line and sits at 99.1% of its 52-week range. The latest completed week returned 27.4%, after a 16.5% four-week move. The latest news-sentiment score is 50/100. Near-term considerations: price is close to its 52-week high.
Setup score
67
out of 100
Latest Close
90.69 CNY
7 Aug 2026
1W Return
27.4%
latest completed week
4W Return
16.5%
short-term follow-through
12W Return
40.2%
quarterly tape
Trend Breadth
98.1%
51 of 52 weeks active
Volume Ratio
1.2x
vs 13-week average
- Next-week expectancy is negative at 41.91% based on similar historical setup states.
- 3 reversal markers appear in the recent smart-money tape.
- Price is close to its 52-week high; watch for continuation or exhaustion.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
27.4%
Latest completed week; four-week move 16.5%.
Indicator stack
78/85
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 41.91%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
1 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 41.1% above the Trend Line and sits at 99.1% of its 52-week range. The latest completed week returned 27.4%, after a 16.5% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.2x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
6 Feb
13 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.4812-week average 0.57
12-week confirmation
Trend active11/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure4/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.48Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers33 reversal markers
No recent accumulation markers. 3 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 16.5% over four weeks, 40.2% over 12 weeks, and 111.3% over one year. The current trend has remained active for 7 consecutive weeks.
Performance by holding period
Active trend streak7 weeks
Active weeks in one year51
Trend breadth98.1%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.63Latest activity-pressure read.
Pressure change290.3%Four-week change in activity pressure.
Leadership63.69Latest relative-leadership reading.
RS change40.9%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 1 relevant articles.
0 positive · 1 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-0.5%Distance below the 52-week high.
13-week volatility12.8%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
6 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher12 of 2614 weeks finished lower.
Best week+27.4%Week of 7 Aug.
Worst week-16.0%Week of 17 Jul.
Latest week+27.4%Week of 7 Aug.
Shape of recent returns
Strong gains9
Modest gains3
Flat weeks0
Modest losses6
Sharp losses8
Recent vol12.8%13-week weekly-return volatility.
Base vol11.3%52-week weekly-return volatility.
Up/down split23/29Count of positive and negative weeks in the 52-week window.
Average skew11.2% / -5.2%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorCN Healthcare
4-week rank- / 100
Group average4.8%
Trend breadth21.0%
Trend21.0%active weekly trend signals
MD64.0%positive activity pressure
RS31.0%positive relative leadership
Four-week leaders
IndustryCN Drug Manufacturers - General
4-week rank2 / 22
Group average3.7%
Trend breadth9.1%
Trend9.1%active weekly trend signals
MD40.9%positive activity pressure
RS18.2%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape64/100
Trend, activity pressure, participation, and risk combine to a 64/100 tape read.
Indicator analysis60/100Latest 12-week confirmation: trend 11/12, activity pressure 4/12, relative leadership 12/12.
Activity pressure 0.48; 3 reversal markers Next-Week ExpectancyNegative 41.91%Next-week expectancy is negative with a 41.91% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 1 relevant articles.
Shanghai InnoStar Bio-tech Co. Ltd. Class A Revenue Breakdown – SSE:688710 Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 90.69 CNY | 27.4% | 64.29 CNY | 45.95 CNY | 0.63 | 63.69 | 16.0M | On |
| 31 Jul 2026 | 71.21 CNY | -7.4% | 62.74 CNY | 45.50 CNY | 0.56 | 34.15 | 14.5M | On |
| 24 Jul 2026 | 76.90 CNY | 17.6% | 61.84 CNY | 45.24 CNY | 0.22 | 46.96 | 22.1M | On |
| 17 Jul 2026 | 65.40 CNY | -16.0% | 60.90 CNY | 44.91 CNY | -0.09 | 28.29 | 39.2M | On |
| 10 Jul 2026 | 77.87 CNY | 24.3% | 60.33 CNY | 44.70 CNY | -0.33 | 45.20 | 19.6M | On |
| 3 Jul 2026 | 62.67 CNY | -3.1% | 59.13 CNY | 44.35 CNY | -0.84 | 17.08 | 4.3M | On |
| 26 Jun 2026 | 64.69 CNY | 13.3% | 58.54 CNY | 44.16 CNY | -0.90 | 22.43 | 2.4M | On |
| 19 Jun 2026 | 57.12 CNY | 5.3% | 57.85 CNY | 43.94 CNY | -0.93 | 7.50 | 8.6M | Off |
| 12 Jun 2026 | 54.26 CNY | -4.7% | 57.57 CNY | 43.79 CNY | -0.66 | 4.24 | 2.2M | On |
| 5 Jun 2026 | 56.96 CNY | -5.9% | 57.25 CNY | 43.68 CNY | -0.27 | 10.11 | 1.5M | On |
| 29 May 2026 | 60.51 CNY | -6.6% | 56.93 CNY | 43.53 CNY | -0.03 | 16.59 | 10.8M | On |
| 22 May 2026 | 64.82 CNY | 0.2% | 56.34 CNY | 43.34 CNY | 0.11 | 24.54 | 11.7M | On |
| 15 May 2026 | 64.67 CNY | -0.7% | 55.56 CNY | 43.10 CNY | 0.08 | 24.81 | 14.0M | On |
| 8 May 2026 | 65.12 CNY | -2.8% | 54.90 CNY | 42.85 CNY | 0.12 | 25.58 | 5.7M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.